First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) Stock Price

First Tracks Biotherapeutics, Inc. Ordinary Shares (NASDAQ: TRAX) last traded at $43.11, up 2.89% on the session. The quote above updates while this page is open; the figures below are drawn from First Tracks Biotherapeutics, Inc. Ordinary Shares’s own filings and are restated only when a new one is published.

First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) company overview

First Tracks Biotherapeutics, Inc. Ordinary Shares trades on NASDAQ under the ticker TRAX. Its market capitalisation is $1.54 billion.

TRAX valuation

Valuation measures for First Tracks Biotherapeutics, Inc. Ordinary Shares, derived from the latest quote and its most recent SEC filing.

TRAX financials

Trailing-twelve-month figures tagged in First Tracks Biotherapeutics, Inc. Ordinary Shares's XBRL filings with the SEC.

TRAX trading statistics

Range and volume for TRAX over the past 52 weeks.

First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) FAQs

What is the TRAX stock price today?

First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) last traded at $43.11, up 2.89% on the session. FurlPay quotes TRAX from Yahoo Finance and stamps each figure with the exchange time it printed.

What exchange is TRAX listed on?

First Tracks Biotherapeutics, Inc. Ordinary Shares is listed on NASDAQ under the ticker symbol TRAX.

What is First Tracks Biotherapeutics, Inc. Ordinary Shares's market cap?

First Tracks Biotherapeutics, Inc. Ordinary Shares has a market capitalisation of $1.54 billion, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.

What is TRAX's 52-week range?

Over the past 52 weeks TRAX has traded between $14.72 and $49.91.